5 Transfusion Nursing Practice Questions
A practical guide to bedside transfusion checks, administration and monitoring, recognizing suspected reactions, and responding and documenting safely.
Verify the patient and component
Before administration, use the required patient identifiers and facility verification process at the bedside. Match the patient to the component label and compatibility information, confirm that the component is intended for that patient, and check that it is within its allowable administration period. A room number or the patient’s stated blood type is not a substitute for these checks.
These requirements apply to blood components, including platelets. Follow the prescriber’s order, facility policy, and transfusion-service instructions, which govern local verification steps and product-specific requirements.
Prepare the line and component
Use the facility-approved . Do not add medications to the blood bag or tubing, and do not administer medications through the same line during transfusion. Normal saline is commonly used when a compatible fluid is needed for the blood line; follow local policy for priming and line management.
For platelets, obtain and record , then administer according to the order and facility policy. Product handling, tubing changes, rate, and special compatibility requirements depend on the product and local transfusion-service policy.
Monitor during administration
Record and follow local schedules for observation and vital signs. Stay with or closely observe the patient during the early part of the transfusion, when serious reactions can begin and may progress quickly. Continue monitoring throughout administration and afterward as indicated, and tell the patient to report new symptoms promptly.
Document required observations, product details, and the transfusion start and finish times. Do not rely only on symptoms reported by the patient or record only the completion time.
Respond to a suspected reaction
At the first suspicion of a , stop the transfusion and promptly assess the patient. Assess airway, breathing, and circulation; support the patient and escalate care according to the patient’s condition and emergency procedures. Do not flush the blood tubing into the patient.
Maintain IV access using new tubing and compatible fluid as directed by policy. Notify the responsible clinician and transfusion service, and retain the component and administration set for investigation when required. Follow local procedures for investigations, product handling, and any decision about restarting.
Assess allergic symptoms
For isolated itching and hives without breathing difficulty, swelling, or a change in vital signs, stop the transfusion initially, assess and monitor for progression, and notify the appropriate clinician. An can progress. Treatment and any decision to restart slowly depend on clinical reassessment and local procedure; do not restart immediately without an order or policy guidance.
Breathing difficulty, facial or airway swelling, hypotension, or other signs of a severe reaction require emergency escalation. The transfusion must not be restarted unless specifically directed by appropriate clinical guidance.
Escalate fever, rigors, and hypotension
Fever and rigors with hypotension can signal a severe reaction, including possible , particularly when the unit appears cloudy. Stop the transfusion, call for urgent clinical assistance, assess and support the patient, and notify the transfusion service. Preserve the unit and tubing as directed by local procedure.
The clinical team and transfusion service may request patient cultures, testing of the component, and other investigations. Do not discard the unit and tubing or continue the transfusion without assessment.
Respond to respiratory distress
Acute respiratory distress during or soon after transfusion may reflect a life-threatening reaction, including or , among other causes. Stop the transfusion, assess and support breathing, monitor vital signs and oxygenation, and seek urgent clinical help through the local reaction pathway.
Distinguishing the cause requires clinical assessment. Do not assume fluid overload or another diagnosis, give treatment before assessing the patient, or restart the transfusion without appropriate direction.
Document and follow up
Complete timely documentation to support patient care and investigation. Record the component and unit details, start and stop times, symptoms and observations, interventions, and whom you notified. Follow local requirements for incident reporting, laboratory samples, and returning the component and administration set.
The appropriate clinical team and transfusion service should be notified, and required product handling and investigations should follow local procedure.